Command Palette

Search for a command to run...

Clinical Trials · NCT02910570

Changes in Skin Autoflouresence Following Weight Loss and Maintenance Using Liraglutide in Knee Osteoarthritis

CompletedPhase 4Liraglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Parker Research Institute
Enrollment
150
Start date
Nov 2016
Locations
1 site, Denmark
Primary endpoint
Change in advanced glycation end products in the skin
View Liraglutide compound reference